This document specifies general requirements for ORGANIZATIONS in the application of RISK MANAGEMENT before, during and after the connection of a HEALTH IT SYSTEM within a HEALTH IT INFRASTRUCTURE, by addressing the KEY PROPERTIES of SAFETY, EFFECTIVENESS and SECURITY whilst engaging appropriate stakeholders.

  • Standard
    39 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document specifies the characteristics of, and corresponding test methods for, the wrought titanium alloy known as titanium 6-aluminium 4-vanadium alloy (Ti-6Al-4V alloy) for use in the manufacture of surgical implants. NOTEÂ Â Â Â Â The mechanical properties of a sample obtained from a finished product made of this alloy might not necessarily comply with the specifications given in this document.

  • Standard
    8 pages
    English language
    sale 15% off
  • Standard
    8 pages
    French language
    sale 15% off
  • Draft
    8 pages
    English language
    sale 15% off
  • Amendment
    27 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Amendment
    52 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document specifies requirements and provides guidelines for an organizational program for working carers providing care to: —   adult care recipients (e.g. adults with cognitive, sensory, physical, and invisible disabilities, adults with chronic or episodic conditions and older dependents); —   long-term childcare recipients (e.g. due to chronic illness or permanent cognitive, sensory or physical disability or injury). This document is applicable to any organization, regardless of size, sector or community setting (i.e. urban, rural or remote). This document can be used in conjunction with an organization’s management systems, human resource programs, and/or equity, diversity and inclusion programs, or on its own in the absence of a formal workplace program to support working carers.

  • Standard
    21 pages
    English language
    sale 15% off
  • Draft
    21 pages
    English language
    sale 15% off
  • Standard
    54 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    50 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document specifies the procedure for the assessment of medical devices and their constituent materials with regard to their potential to induce skin sensitization. This document includes: —   details of in vivo skin sensitization test procedures; —   key factors for the interpretation of the results. NOTE     Instructions for the preparation of materials specifically in relation to the above tests are given in Annex A.

  • Standard
    48 pages
    English language
    sale 15% off
  • Standard
    51 pages
    French language
    sale 15% off
  • Draft
    58 pages
    English language
    sale 15% off
  • Draft
    58 pages
    French language
    sale 15% off

This document applies to ocular endotamponades (OE), a group of non-solid surgically invasive medical devices introduced into the vitreous cavity of the eye to flatten and position a detached retina onto the retinal pigment epithelium (RPE), or to tamponade the retina.
With regard to the safety and efficacy of OE, this document specifies requirements for their intended performance, design attributes, pre-clinical and clinical evaluation, sterilization, product packaging, product labelling and the information supplied by the manufacturer.

  • Standard
    23 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    22 pages
    English language
    sale 10% off
    e-Library read for
    1 day

Resolution BT C87/2011 (extension of DOW): DOW = DAV + 36 months

  • Standard
    25 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    22 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Standard
    25 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    22 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document specifies general requirements for medical suction equipment that are common to all parts of the 10079 series.
The ISO 10079 series does not apply to the following:
a)   end-pieces such as suction catheters, drains, curettes, Yankauer suckers and suction tips;
b)   syringes;
c)   dental suction equipment;
d)   anaesthetic gas scavenging systems;
e)   laboratory suction;
f)   autotransfusion systems;
g)   mucus extractors including neonatal mucus extractors;
h)   suction equipment where the collection container is downstream of the vacuum pump;
i)   ventouse (obstetric) equipment;
j)   suction equipment marked for endoscopic use only
k)   plume evacuation systems.

  • Standard
    43 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    39 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document specifies the general requirements for configuration, materials, performance and safety requirements of moxibustion devices. It also specifies the minimum requirements for moxibustion materials used in moxibustion devices. It is applicable across a wide range of moxibustion devices that use moxa floss as the main combustion material and can remain on or over the body throughout the moxibustion process. It is applicable to moxibustion devices for both single and repeated usage. This document does not apply to devices that imitate moxibustion, such as electro-moxibustion and infrared moxibustion devices that do not involve the use of moxa floss. It also does not apply to moxa floss used in direct moxibustion.

  • Standard
    11 pages
    English language
    sale 15% off
  • Draft
    11 pages
    English language
    sale 15% off
  • Technical specification
    43 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This European Standard specifies requirements and the relevant tests for large steam sterilizers primarily used in health care for the sterilization of medical devices and their accessories contained in one or more sterilization modules. The test loads described in this European Standard are selected to represent the majority of loads (i.e. wrapped goods consisting of metal, rubber and porous materials) for the evaluation of general purpose steam sterilizers for medical devices. However, specific loads (e.g. heavy metal objects or long and/or narrow lumen) will require the use of other test loads.
This European Standard applies to steam sterilizers designed to accommodate at least one sterilization module or having a chamber volume of at least 60 l.
Large steam sterilizers can also be used during the commercial production of medical devices.
This European Standard does not specify requirements for equipment intended to use, contain or be exposed to flammable substances or substances which could cause combustion. This European Standard does not specify requirements for equipment intended to process biological waste or human tissues.
This European Standard does not describe a quality management system for the control of all stages of the manufacture of the sterilizer.
NOTE 1   Attention is drawn to the standards for quality management systems e.g. EN ISO 13485.
NOTE 2   Environmental aspects are addressed in Annex A.

  • Standard
    118 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document specifies requirements and test methods for operating lights used in the dental office and intended for illuminating the oral cavity of patients. It also contains specifications on the instructions for use, marking and packaging. This document applies to operating lights, irrespective of the technology of the light source. This document excludes auxiliary light sources, for example, from dental handpieces and dental headlamps and also operating lights which are specifically designed for use in oral surgery.

  • Standard
    21 pages
    English language
    sale 15% off
  • Standard
    23 pages
    French language
    sale 15% off
  • Draft
    22 pages
    English language
    sale 15% off
  • Draft
    22 pages
    French language
    sale 15% off

This document specifies the appropriate application of ISOÂ 17327-1:2018 to coated endovascular prostheses, vascular stents, and vena cava filters. This document is intended to be used as a supplement to ISOÂ 25539-1, ISOÂ 25539-2, ISOÂ 25539-3, ISOÂ 12417-1 and ISO/TSÂ 17137. The following coatings are within the scope of ISOÂ 17327-1 and addressed in this document for endovascular devices: drug coatings (eluting and non-eluting), non-drug coatings (absorbable and non-absorbable), and chemistry-related surface modifications (oxide, such as TiO2, and non-oxide, such as amorphous silicon carbide and diamond-like carbon). This document is not applicable to coated delivery systems or coated ancillary devices (e.g. guidewires), as these coatings are not within the scope of ISOÂ 17327-1, which is specifically directed to implant coatings. This document is not applicable to coverings of endovascular devices; however, if the covering of a device is coated, it is within the scope of this document. This document does not address the requirements for, and the evaluation of, viable tissues and non-viable biologic materials used as implant coatings.

  • Standard
    11 pages
    English language
    sale 15% off

IEC 62563-2:2021 establishes the performance CRITERIA and test frequencies for the ACCEPTANCE TESTS and CONSTANCY TESTS. The evaluation methods are defined in IEC 62563-1. The scope of this document is directed to practical tests that can be visually evaluated or measured using basic test equipment. This document applies to medical IMAGE DISPLAY SYSTEMS, which can display monochrome image information in the form of greyscale values on colour and greyscale IMAGE DISPLAY SYSTEMS. This document does not apply to information displays and to displays used solely for control of technical settings of all medical information.

  • Standard
    71 pages
    English and French language
    sale 15% off

This document specifies the general requirements and test methods for diamond rotary instruments used in dentistry, including designation, colour code and grit sizes and a quality control for these instruments. It applies to all types of diamond rotary instruments independent of type and shape with exception to diamond discs, which are specified in ISO 7711-2.

  • Standard
    11 pages
    English language
    sale 15% off
  • Standard
    11 pages
    French language
    sale 15% off
  • Draft
    11 pages
    English language
    sale 15% off
  • Draft
    11 pages
    French language
    sale 15% off

This standard specifies requirements and test methods for single-use evacuated and non-evacuated
receptacles, intended by their manufacturers, for the primary containment and preservation of
specimens, other than blood specimens, derived from the human body, for the purposes of in vitro
diagnostic examination.
NOTE 1 Requirements and test methods for evacuated and non-evacuated single-use venous blood
specimen containers are specified in EN ISO 6710.
NOTE 2 While it is desirable that specimen receptacles should be designed to avoid spontaneous
discharge of the contents, when being opened, this standard does not specify a test procedure for this
because it has not been possible to devise an objective and reproducible test.
This standard does not specify requirements for collection needles or needle holders or other
accessories used in conjunction with specimen receptacles.

  • Standard
    21 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    18 pages
    English language
    sale 10% off
    e-Library read for
    1 day

MINOR REVISION
ISO missed to notify CCMC - deadline extended for 1 week.

  • Standard
    34 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    29 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document applies to the basic safety and essential performance of ventilatory high-flow therapy equipment, as defined in 201.3.204, hereafter also referred to as ME equipment, in combination with its accessories:
- intended for use in the home healthcare environment;
- intended for use in professional healthcare facilities;
- intended for use by a lay operator or a healthcare professional operator;
- intended for use with patients who can breathe spontaneously;
- intended for patients who would benefit from improved alveolar gas exchange; and who would benefit from receiving high-flow humidified respiratory gases, including a patient whose upper airway is bypassed; and
EXAMPLE 1 Patients with Type 1 Respiratory Failure, which exhibits a reduction in arterial blood oxygenation or patients who would benefit from reduced work of breathing, as needed in Type 2 Respiratory Failure, where arterial carbon dioxide is high.
- not intended for patients who are dependent on artificial ventilation for their life support.
NOTE 1 In the home healthcare environment, the supply mains is often not reliable.
Ventilatory high-flow therapy equipment is typically composed of four parts:
1) gas sources,
- air, and
- if needed, oxygen;
NOTE 2 Gas sources include medical gas pipeline systems, gas cylinders, oxygen concentrators and ambient air.
2) humidifier;
NOTE 3 When dry gas is utilized, a humidifier is typically needed.
3) breathing tube;
4) a patient interface, which is used to deliver gas to the patient; and
5) a flow controller, which is used to select and deliver the desired flow.
NOTE 4 The flow controller can be at a fixed rate.
NOTE 5 The flowrate range is dependent upon the intended patient population (e.g., neonatal, paediatric and adult patients can require different flowrates).
These parts can be combined (e.g., the gas source and humidifier can be combined). Ventilatory highflow therapy equipment interfaces with the patient whose upper airway is intact via a nasal cannula or mask as well as a patient whose upper airway is bypassed via an endotracheal tube, oropharyngeal mask, or tracheostomy.
Ventilatory high-flow therapy equipment can be transit-operable.
This document is also applicable to those accessories intended by their manufacturer to be connected to the ventilatory high-flow therapy equipment, where the characteristics of those accessories can affect the basic safety or essential performance of the ventilatory high-flow therapy equipment.
EXAMPLE 2 Breathing sets, connectors, water traps, expiratory valve, humidifier, breathing system filter, external electrical power source, distributed alarm system.
This document does not specify the requirements for:
- ventilators or accessories for ventilator-dependent patients intended for critical care applications, which are given in ISO 80601 2 12;
- ventilators or accessories intended for anaesthetic applications, which are given in ISO 80601 2 13;
- ventilators or accessories intended for the emergency medical services environment, which are given in ISO 80601 2 84;
- ventilators or accessories intended for ventilator-dependent patients in the home healthcare environment, which are given in ISO 80601 2 72;
- ventilatory support equipment or accessories intended for ventilatory impairment, which are given in ISO 80601 2 79;
- ventilatory support equipment or accessories intended for ventilatory insufficiency, which are given in ISO 80601 2 80;
- sleep apnoea therapy ME equipment, which are given in ISO 80601 2 70;
- continuous positive airway pressure (CPAP) ME equipment;
- high-frequency jet ventilators (HFJVs);
- high-frequency oscillatory ventilators (HFOVs), which are given in ISO 80601 2 87; and
- cuirass or "iron-lung" ventilation equipment.
NOTE 4 Ventilatory high-flow therapy equipment can be incorporated into any of the above equipment, in which case those standards would be applicable for those ventilation-modes.
This docum.....

  • Standard
    99 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    89 pages
    English language
    sale 10% off
    e-Library read for
    1 day

2021-08-09: following BT decision 131/2021, to be published with Annex ZA and ZB for MDR (EU) 2017/745 and the IVDR (EU) 2017/746 even if negative assessment (SV)
2021-07-14 - Lack of compliance - publication on hold.

  • Standard
    63 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    48 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document provides guidance for the application of the requirements contained in ISO 11607-1 and ISO 11607-2. It does not add to, or otherwise change, the requirements of ISO 11607-1 and ISO 11607-2. This is an informative document, not normative. It does not include requirements to be used as basis of regulatory inspection or certification assessment activities. The guidance can be used to better understand the requirements of ISO 11607-1 and ISO 11607-2 and illustrates the variety of methods and approaches available for meeting the requirements of those International Standards. It is not required that this document be used to demonstrate conformity with them. Guidance is given for evaluation, selection and use of packaging materials, preformed sterile barrier systems, sterile barrier systems and packaging systems. Guidance on validation requirements for forming, sealing and assembly processes is also given. This document provides information for both healthcare facilities and the medical devices industry for terminally sterilized medical devices. This document does not provide guidance for applications of packaging materials and systems after their opening. In the use of packaging for other purposes such as a “sterile field” or transport of contaminated items, other regulatory standards will apply.

  • Technical specification
    143 pages
    English language
    sale 15% off
  • Technical specification
    153 pages
    French language
    sale 15% off
  • Draft
    142 pages
    English language
    sale 15% off

This document specifies the basic terminology and classification of tongue diagnostic methods. Each term of tongue diagnosis includes the English name, the classical Chinese characters and its definition. The classification structure of tongue diagnosis terms is shown in Figure 1.

  • Standard
    36 pages
    English language
    sale 15% off
  • Draft
    36 pages
    English language
    sale 15% off

This document specifies the basic terminology of pulse diagnostic methods, the key elements of pulse and pulse condition. Each term of pulse diagnosis includes the English name, the classical Chinese characters and its definition.

  • Standard
    21 pages
    English language
    sale 15% off
  • Draft
    21 pages
    English language
    sale 15% off

This document specifies apparatus, test methods, and disclosure requirements for characterization of wheelchair seat cushion immersion and envelopment properties using indenters instrumented with pressure sensors. This document expands the characterization of products intended to manage tissue integrity (ISO 16840‑2) and provides a standardized indenter for other wheelchair seating tests. It does not provide information specific to cushion performance for a particular individual user, nor is it intended to characterize envelopment or immersion under higher loading conditions, nor to assess the weight capacity of a cushion. This document includes a method that is specific to 220 mm and 255 mm indenters. Dimensions are provided for a 380 mm indenter to allow for extension of the method to larger patient simulation.

  • Standard
    15 pages
    English language
    sale 15% off
  • Draft
    15 pages
    English language
    sale 15% off

This document specifies requirements for water-absorbent crosslinked polyacrylate in urine absorbing products.

  • Standard
    3 pages
    English language
    sale 15% off
  • Draft
    3 pages
    English language
    sale 15% off

2021-08-25-JO: BT Decision (BT169/DG12292/DV) to remove the link to the MDR
2021-06-24: blocked so that the link to the MDD can be removed by BT from the document
2019-12-03-JO-Assessment at ENQ uplaoded with due date of 06 Jan.2020 plus extention requested by HAS Consultant

  • Amendment
    58 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document specifies the quality and safety requirements of Zingiber officinale rhizome derived from the plant Zingiber officinale Roscoe, including the minimum requirements and test methods. This document applies to Zingiber officinale rhizome that is sold and used as natural medicines in international trade, including Chinese materia medica (whole medicinal materials) and decoction pieces derived from this plant. It is not applicable to Zingiber officinale rhizome sold and used as food or spices.

  • Standard
    15 pages
    English language
    sale 15% off
  • Draft
    15 pages
    English language
    sale 15% off

This document specifies requirements and recommendations on the handling, storage, processing and documentation of saliva specimens intended for human DNA examination during the pre-examination phase before a molecular examination is performed. This document is applicable to molecular in vitro diagnostic examination including laboratory developed tests performed by medical laboratories. It can also be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities. Dedicated measures that need to be taken for saliva collected on absorbing material or by mouth washes are not described in this document. Neither are measures for preserving and handling of native saliva cell-free DNA, pathogens, and other bacterial or whole microbiome DNA in saliva described. NOTEÂ Â Â Â Â Â International, national or regional regulations or requirements can also apply to specific topics covered in this document.

  • Standard
    12 pages
    English language
    sale 15% off
  • Standard
    14 pages
    French language
    sale 15% off
  • Draft
    12 pages
    English language
    sale 15% off
  • Draft
    12 pages
    French language
    sale 15% off

This document specifies requirements and test methods for hoists and body-support units intended for the transfer of persons with disabilities. The document applies to the following products classified in ISO 9999:—[1]. —   12 36 03 Mobile hoists for transferring a person in sitting position with sling seats; —   12 36 04 Mobile hoists for transferring a person in standing position; —   12 36 06 Mobile hoists for transferring a person in sitting position with solid seats; —   12 36 09 Mobile hoists for transferring a person in lying position; —   12 36 12 Stationary hoists fixed to walls, floor or ceiling; —   12 36 15 Stationary hoists fixed to, or mounted in or on, another product; —   12 36 18 Stationary free-standing hoists; —   12 36 21 Body-support units for hoists. This document covers different types of mobile and stationary hoists. Some of the requirements and test methods are general and others are only valid for specific product types. Annexes A, B and C provide general recommendations. This document does not apply to devices that transport persons between two levels (floors) of a building. It does not include methods for the determination of ageing or corrosion of such hoists and units. It does not include methods to qualify individual units prior to use. The requirements of this document are formulated with regard to the needs of both the persons being hoisted and the attendant using the hoist.  [1] Under preparation. Stage at the time of publication: ISO/FDIS 9999:2021.

  • Standard
    75 pages
    English language
    sale 15% off
  • Standard
    82 pages
    French language
    sale 15% off
  • Draft
    75 pages
    English language
    sale 15% off
  • Draft
    75 pages
    French language
    sale 15% off

IEC 80601-2-77:2019 applies to the BASIC SAFETY and ESSENTIAL PERFORMANCE of ROBOTICALLY ASSISTED SURGICAL EQUIPMENT (RASE) and ROBOTICALLY ASSISTED SURGICAL SYSTEMS (RASS), referred to as ME EQUIPMENT and ME SYSTEMS together with their INTERACTION CONDITIONS and INTERFACE CONDITIONS.

  • Standard
    55 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document specifies test methods to determine microorganisms in natural products. It is applicable only to natural products used in traditional Chinese medicine, including raw materials, herbal pieces and preparations.

  • Standard
    40 pages
    English language
    sale 15% off
  • Draft
    40 pages
    English language
    sale 15% off

This document describes a method for testing the susceptibility to antifungal agents of yeasts, including Candida spp. and Cryptococcus neoformans, that cause infections. The reference method described here has not been used in studies of the yeast forms of dimorphic fungi, such as Blastomyces dermatitidis and/or Histoplasma capsulatum variety capsulatum. Moreover, testing filamentous fungi (moulds) introduces several additional problems in standardization not addressed by the current procedure. Those methods are beyond the scope of this document. This document describes the broth micro-dilution reference method, which can be implemented by either of two pathways. One pathway involves visual determination of MICs (CLSI method)[1][5]; the second pathway involves spectrophotometric determination of MICs (EUCAST method)[2][10]. The MIC reflects the activity of the drug under the described test conditions and can be interpreted for clinical management purposes by taking into account other factors, such as drug pharmacology or antifungal resistance mechanisms. In addition, MIC distributions can be used to define wild type or non-wild type fungal populations. Clinical interpretation of the MIC value is beyond the scope of this document; interpretive category breakpoints specific to the CLSI- and EUCAST-derived methods can be found by consulting the latest interpretive tables provided by the organizations[5][15]. Routine susceptibility testing methods or diagnostic test devices can be compared with this reference method in order to ensure comparable and reliable results for validation or registration purposes.

  • Standard
    16 pages
    English language
    sale 15% off
  • Standard
    17 pages
    French language
    sale 15% off
  • Draft
    16 pages
    English language
    sale 15% off

This document specifies general requirements for plasma-sprayed titanium coatings on metallic surgical implants. This document applies to atmospheric plasma spraying and vacuum plasma spraying. This document does not apply to coatings made of other materials than titanium or titanium-6 aluminum-4 vanadium alloy or to coatings realized by another technology than plasma spraying. NOTEÂ Â Â Â Â Â A quality management system can be useful, e.g. as described in ISOÂ 13485. Requirements for the competence of testing laboratories can be found in ISO/IECÂ 17025.

  • Standard
    6 pages
    English language
    sale 15% off
  • Standard
    6 pages
    French language
    sale 15% off
  • Draft
    6 pages
    English language
    sale 15% off
  • Draft
    6 pages
    French language
    sale 15% off
  • Technical specification
    42 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Technical specification
    38 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document specifies general requirements for ORGANIZATIONS in the application of RISK MANAGEMENT before, during and after the connection of a HEALTH IT SYSTEM within a HEALTH IT INFRASTRUCTURE, by addressing the KEY PROPERTIES of SAFETY, EFFECTIVENESS and SECURITY whilst engaging appropriate stakeholders. IEC 80001-1:2021 cancels and replaces the first edition published in 2010. This edition constitutes a technical revision. This edition includes the following significant technical changes with respect to the previous edition: a) structure changed to better align with ISO 31000; b) establishment of requirements for an ORGANIZATION in the application of RISK MANAGEMENT; c) communication of the value, intention and purpose of RISK MANAGEMENT through principles that support preservation of the KEY PROPERTIES during the implementation and use of connected HEALTH SOFTWARE and/or HEALTH IT SYSTEMS.

  • Draft
    31 pages
    English language
    sale 15% off

IEC 80001-1:2021 specifies general requirements for ORGANIZATIONS in the application of RISK MANAGEMENT before, during and after the connection of a HEALTH IT SYSTEM within a HEALTH IT INFRASTRUCTURE, by addressing the KEY PROPERTIES of SAFETY, EFFECTIVENESS and SECURITY whilst engaging appropriate stakeholders.
IEC 80001-1:2021 cancels and replaces the first edition published in 2010. This edition constitutes a technical revision.
This edition includes the following significant technical changes with respect to the previous edition:
a) structure changed to better align with ISO 31000;
b) establishment of requirements for an ORGANIZATION in the application of RISK MANAGEMENT;
c) communication of the value, intention and purpose of RISK MANAGEMENT through principles that support preservation of the KEY PROPERTIES during the implementation and use of connected HEALTH SOFTWARE and/or HEALTH IT SYSTEMS.

  • Standard
    75 pages
    English and French language
    sale 15% off

This document establishes design evaluation requirements and recommendations for absorbable cardiovascular implants used to treat vessels and/or the vascular space within the circulatory system, including the heart and all vasculature. This document is intended to supplement device-specific standards by providing guidelines specific for either absorbable implants or components, or both. This document is applicable to implants in direct contact with the cardiovascular system, where the intended action is upon the circulatory system. This document does not address the specific evaluation of issues associated with viable tissues, viable cells, and/or implants with non-viable biological materials and their derivatives. Additionally, procedures and devices used prior to and following the introduction of the absorbable cardiovascular implant (e.g. balloon angioplasty devices) are excluded from the scope of this document if they do not affect the absorption aspects of the implant. A cardiovascular absorbable implant can incorporate substance(s) which, if used separately, can be considered to be a medicinal product (drug product) but the action of the medicinal substance is ancillary to that of the implant and supports the primary mode of action of the implant. NOTE 1   Some aspects of absorbable components of cardiovascular device-drug combination products (e.g. coatings) in their connection with drug-related aspects of the device are addressed in ISO 12417-1. NOTE 2   An explanation of the nomenclature of absorb, degrade and related terms can be found in Annex A.

  • Technical specification
    36 pages
    English language
    sale 15% off
  • Draft
    36 pages
    English language
    sale 15% off

This document establishes the specifications for the dimensions of various endodontic obturating materials including preformed metal, preformed polymeric-coated metal, polymeric points, thermoplastic obturating material or combinations of the above, suitable for use in the obturation of the root canal system. This document also specifies numerical systems and a colour-coding system for designating the sizes of preformed endodontic obturating points. Dental endodontic obturating points are marketed sterilized or non-sterilized. This document covers the physical attributes expected of such products as supplied. Sterility is not included in this document, and any claim that the product is sterile is the responsibility of the manufacturer (see Table 3). Clause 7 specifies the labelling needed, including the instructions for use. This document does not apply to instruments or apparatus used in conjunction with thermoplastic obturating materials (obturating material that deform with heat). This document is not applicable to materials for support of a coronal restoration.

  • Standard
    17 pages
    English language
    sale 15% off
  • Standard
    19 pages
    French language
    sale 15% off
  • Draft
    18 pages
    English language
    sale 15% off
  • Draft
    20 pages
    French language
    sale 15% off

This document specifies procedures and test methods used to demonstrate the cleaning efficacy of
washer-disinfectors (WD) and their accessories intended to be used for cleaning of reusable medical
devices.
NOTE 1 The requirements can be used for washer-disinfectors intended for use with other articles used in the
context of medical, dental, laboratory, pharmaceutical and veterinary practice.
NOTE 2 This document does not apply to the activities to be performed by the manufacturers of reusable
medical devices.

  • Standard
    68 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    45 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document provides recommended and other product type names and example pictures of product
categories defined in ISO 9999, subclass 09 30, "Absorbing products to contain urine and faeces".

  • Standard
    16 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    13 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document specifies the requirements and test methods for hydrocolloid impression materials. This document helps to determine whether elastic aqueous agar and alginate hydrocolloid dental impression materials, as prepared for retail marketing, are of the quality needed for their intended purposes. It also specifies requirements for labelling and instructions for use. This document does not address possible biological hazards associated with the materials. Assessment of these hazards is addressed in ISOÂ 7405 and the ISOÂ 10993 series.

  • Standard
    46 pages
    English language
    sale 15% off
  • Standard
    48 pages
    French language
    sale 15% off
  • Draft
    46 pages
    English language
    sale 15% off

This document specifies general requirements for medical suction equipment that are common to all parts of the ISO 10079 series. This document is not applicable to the following: a) end-pieces such as suction catheters, drains, curettes, Yankauer suckers and suction tips; b) syringes; c) dental suction equipment; d) anaesthetic gas scavenging systems; e) laboratory suction; f) autotransfusion systems; g) mucus extractors including neonatal mucus extractors; h) suction equipment where the collection container is downstream of the vacuum pump; i) ventouse (obstetric) equipment; j) suction equipment marked for endoscopic use only; and k) plume evacuation systems.

  • Standard
    35 pages
    English language
    sale 15% off
  • Draft
    35 pages
    English language
    sale 15% off

This document applies to the basic safety and essential performance of respiratory high-flow therapy equipment, as defined in 201.3.220, hereafter also referred to as ME equipment or ME system, in combination with its accessories:
- intended for use with patients who can breathe spontaneously; and
- intended for patients who would benefit from improved alveolar gas exchange; and who would benefit from receiving high-flow humidified respiratory gases, which can include a patient whose upper airway is bypassed.
EXAMPLE 1 Patients with Type 1 Respiratory Failure who exhibit a reduction in arterial blood oxygenation.
EXAMPLE 2 Patients who would benefit from reduced work of breathing, as needed in Type 2 Respiratory Failure, where arterial carbon dioxide is high.
EXAMPLE 3 Patients requiring humidification to improve mucociliary clearance.
Respiratory high-flow therapy equipment can be intended for use in the home healthcare environment or intended for use in professional healthcare facilities.
NOTE 1 In the home healthcare environment, the supply mains is often not reliable.
Respiratory high-flow therapy equipment can be:
- fully integrated ME equipment; or
- a combination of separate items forming a ME system.
This standard also applies to other types of respiratory equipment when that equipment includes a respiratory high-flow therapy mode.
NOTE 2 This standard and ISO 80601-2-12[14] are applicable to a critical care ventilator with a high-flow therapy mode.
Respiratory high-flow therapy equipment can be transit-operable.
This document is also applicable to those accessories intended by their manufacturer to be connected to the respiratory high-flow therapy equipment, where the characteristics of those accessories can affect the basic safety or essential performance of the respiratory high-flow therapy equipment.
EXAMPLE 4 Breathing sets, connectors, humidifier, breathing system filter, external electrical power source, distributed alarm system, high-flow nasal cannula, tracheal tube, tracheostomy tube, face mask and supra-laryngeal airway.
If a clause or subclause is specifically intended to be applicable to ME equipment only, or to ME systems only, the title and content of that clause or subclause will say so. If that is not the case, the clause or subclause applies both to ME equipment and to ME systems, as relevant.
Hazards inherent in the intended physiological function of ME equipment or ME systems within the scope of this document are not covered by specific requirements in this document except in the general standard, 7.2.13 and 8.4.1.
NOTE 3 Additional information can be found in the general standard, 4.2.
This document does not specify the requirements for:
- ventilators or accessories for ventilator-dependent patients intended for critical care applications, which are given in ISO 80601‑2‑12[14];
- ventilators or accessories intended for anaesthetic applications, which are given in ISO 80601‑2‑13[15];
- ventilators or accessories intended for the emergency medical services environment, which are given in ISO 80601‑2‑84[20];
- ventilators or accessories intended for ventilator-dependent patients in the home healthcare environment, which are given in ISO 80601‑2‑72[17];
- ventilatory support equipment or accessories intended for patients with ventilatory impairment, which are given in ISO 80601‑2‑79[18];
- ventilatory support equipment or accessories intended for patients with ventilatory insufficiency, which are given in ISO 80601‑2‑80[19];
- sleep apnoea therapy ME equipment, which are given in ISO 80601‑2‑70[16];
- continuous positive airway pressure (CPAP) ME equipment;
- high-frequency jet ventilators (HFJVs)[31], which are given in ISO 80601‑2‑87[21];
- gas mixers for medical use, which are given in ISO 11195[9];
- flowmeters, which are given in ISO 15002[11];
- high-frequency oscillatory ventilators (HFOVs), which are given in ISO 80601‑2‑87[21]; and
- cuirass or “iron-lung” venti

  • Standard
    89 pages
    English language
    sale 15% off

This document applies to the basic safety and essential performance of respiratory high-flow therapy equipment, as defined in 201.3.220, hereafter also referred to as ME equipment or ME system, in combination with its accessories: —  intended for use with patients who can breathe spontaneously; and —  intended for patients who would benefit from improved alveolar gas exchange; and who would benefit from receiving high-flow humidified respiratory gases, which can include a patient whose upper airway is bypassed. EXAMPLE 1 Patients with Type 1 Respiratory Failure who exhibit a reduction in arterial blood oxygenation. EXAMPLE 2 Patients who would benefit from reduced work of breathing, as needed in Type 2 Respiratory Failure, where arterial carbon dioxide is high. EXAMPLE 3 Patients requiring humidification to improve mucociliary clearance. Respiratory high-flow therapy equipment can be intended for use in the home healthcare environment or intended for use in professional healthcare facilities. NOTE 1       In the home healthcare environment, the supply mains is often not reliable. Respiratory high-flow therapy equipment can be: —  fully integrated ME equipment; or —  a combination of separate items forming a ME system. This standard also applies to other types of respiratory equipment when that equipment includes a respiratory high-flow therapy mode. NOTE 2 This standard and ISO 80601-2-12[14] are applicable to a critical care ventilator with a high-flow therapy mode. Respiratory high-flow therapy equipment can be transit-operable. This document is also applicable to those accessories intended by their manufacturer to be connected to the respiratory high-flow therapy equipment, where the characteristics of those accessories can affect the basic safety or essential performance of the respiratory high-flow therapy equipment. EXAMPLE 4        Breathing sets, connectors, humidifier, breathing system filter, external electrical power source, distributed alarm system, high-flow nasal cannula, tracheal tube, tracheostomy tube, face mask and supra-laryngeal airway. If a clause or subclause is specifically intended to be applicable to ME equipment only, or to ME systems only, the title and content of that clause or subclause will say so. If that is not the case, the clause or subclause applies both to ME equipment and to ME systems, as relevant. Hazards inherent in the intended physiological function of ME equipment or ME systems within the scope of this document are not covered by specific requirements in this document except in the general standard, 7.2.13 and 8.4.1. NOTE 3       Additional information can be found in the general standard, 4.2. This document does not specify the requirements for: —   ventilators or accessories for ventilator-dependent patients intended for critical care applications, which are given in ISO 80601‑2‑12[14]; —   ventilators or accessories intended for anaesthetic applications, which are given in ISO 80601‑2‑13[15]; —   ventilators or accessories intended for the emergency medical services environment, which are given in ISO 80601‑2‑84[20]; —   ventilators or accessories intended for ventilator-dependent patients in the home healthcare environment, which are given in ISO 80601‑2‑72[17]; —   ventilatory support equipment or accessories intended for patients with ventilatory impairment, which are given in ISO 80601‑2‑79[18]; —   ventilatory support equipment or accessories intended for patients with ventilatory insufficiency, which are given in ISO 80601‑2‑80[19]; —   sleep apnoea therapy ME equipment, which are given in ISO 80601‑2‑70[16]; —   continuous positive airway pressure (CPAP) ME equipment; —   high-frequency jet ventilators (HFJVs)[31], which are given in ISO 80601‑2‑87[21]; —   gas mixers for medical use, which are given in

  • Standard
    89 pages
    English language
    sale 15% off
  • Standard
    100 pages
    French language
    sale 15% off
  • Draft
    89 pages
    English language
    sale 15% off
  • Draft
    100 pages
    French language
    sale 15% off

This document specifies requirements and test methods for specialized single-use evacuated and non-evacuated containers, intended by their manufacturers, for the primary containment and preservation of specimens, other than blood specimens, derived from the human body, for the purposes of in vitro diagnostic examination. It is not intended to cover specimen containers for forensic investigations. Examples of such specimens include, but are not limited to, cerebral spinal fluid (CSF), faeces, infected bodily fluids, saliva, ejaculate, sputum, urine, tissue samples. Specimens and types of devices specifically excluded are specialized containers for cryo-preservation, samples for nucleic acid testing and swabs. NOTEÂ Â Â Â Â Â Requirements and test methods for evacuated and non-evacuated single-use human venous blood specimen collection containers are specified in ISOÂ 6710. This document does not specify requirements for auxiliary devices used in conjunction with specimen containers.

  • Standard
    14 pages
    English language
    sale 15% off
  • Standard
    15 pages
    French language
    sale 15% off
  • Draft
    14 pages
    English language
    sale 15% off
  • Draft
    13 pages
    French language
    sale 15% off

1.1 This document specifies the requirements for a test method to be utilized to establish or confirm a reduced incubation time (RIT) that is shorter than the 7 day reference incubation time specified in 7.3.22 of ISO 11138-1:2017 for biological indicators used to monitor moist heat sterilization processes or ethylene oxide (EO) sterilization processes.
1.2 This document is applicable to manufacturers of biological indicators and to end users of biological indicators who intend to, if required by their quality system, establish, validate or confirm an RIT.
1.3 This document is not applicable to biological indicators used to monitor dry heat, low temperature steam formaldehyde (LTSF) or vaporized hydrogen peroxide (VH2O2) sterilization processes.
NOTE 1 The method described in this document to establish an RIT for biological indicators used to monitor moist heat or EO sterilization processes has been used extensively for many years. However, there is limited experience in use of this method to establish an RIT for biological indicators used to monitor dry heat, low temperature steam formaldehyde or vaporized hydrogen peroxide sterilization processes. This document, therefore, does not include these sterilization processes.
NOTE 2 For EO as a sterilizing agent, the stated RIT will be applicable for any EO cycle type, i.e. 100% EO, EO blends, etc.

  • Standard
    15 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    12 pages
    English language
    sale 10% off
    e-Library read for
    1 day

This document gives requirements for the collection, handling, documentation, transport, storage and processing during the pre-examination phase of formalin-fixed and paraffin-embedded (FFPE) tissue specimens intended for examinations of morphology and biomolecules, such as metabolites, proteins, DNA and/or RNA in situ on FFPE tissue sections by using different in situ detection techniques.
This document is applicable to routine and molecular diagnostic examinations using in situ detection techniques including laboratory developed tests performed by routine pathology laboratories (histology laboratories) as well as molecular pathology laboratories and other medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, as well as institutions and commercial organizations performing biomedical research, biobanks, and regulatory authorities.
This document is not applicable for the examination of isolated biomolecules such as proteins, DNA and RNA that cannot be mapped with a defined region of a FFPE section.
NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.

  • Standard
    35 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    31 pages
    English language
    sale 10% off
    e-Library read for
    1 day